In adults with cancer and VTE, DOACs were noninferior to LMWH for recurrent, nonfatal VTE at 6 mo.

Authors :: Bannow BTS
Source :: Annals of internal medicine [Ann Intern Med] 2023 Sep; Vol. 176 (9), pp. JC104. Date of Electronic Publication: 2023 Sep 05.
Publication Year :: 2023
Abstract: Source Citation: Schrag D, Uno H, Rosovsky R, et al; CANVAS Investigators. Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial. JAMA. 2023;329:1924-1933. 37266947.<br />Competing Interests: Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J23-0067.

Subjects :: Adult
Humans
Anticoagulants adverse effects
Heparin, Low-Molecular-Weight therapeutic use
Research Personnel
Randomized Controlled Trials as Topic
Neoplasms complications
Venous Thromboembolism drug therapy

Full Text Access

Tools